The report provides a detailed analysis essential for establishing a mometasone (Nasonex) production plant. It encompasses all critical aspects necessary for mometasone (Nasonex) production, including the cost of mometasone (Nasonex) production, mometasone (Nasonex) plant cost, mometasone (Nasonex) production costs, and the overall mometasone (Nasonex) production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a mometasone (Nasonex) production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Mometasone (Nasonex) is a kind of corticosteroid drug that is majorly known for its applications in the medical industry. It is extensively used as a medication for the treatment of asthma, pruritus, dermatitis, and nasal congestion. Moreover, it also finds its application as a nasal spray to prevent and treat symptoms of allergic rhinitis, including runny nose and sneezing. Additionally, the drug is also employed as an ointment or lotion as a treatment for various inflammatory skin diseases, which include dermatitis, psoriasis, etc., and as an inhaler to manage symptoms of asthma. It is often utilized in research activities for the development of new drug delivery mechanisms.
The market for mometasone (Nasonex) is majorly driven by its broad usage as a steroid medication for the treatment of allergic rhinitis, nasal polyps, and other inflammatory conditions, which remarkably increases its demand in the pharmaceutical industry. Moreover, its utilization in the form of an inhaler for the treatment of asthma or any inflammation in the airways further enhances its demand in the medical and pharmaceutical industries.
Additionally, its employment in the biotechnology and research & development industries for clinical studies and new drug formulations effectively amplifies its market growth. Furthermore, several factors influence industrial mometasone (Nasonex) procurement, such as the availability of raw materials (2-furoyl chloride-dichloromethane, etc.), cost and pricing, compliance with medical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Mometasone (Nasonex) Production
According to the Mometasone (Nasonex) production plant project report, the major raw materials for Mometasone (Nasonex) production include 16α-methyl-1l,4,9(11)-pregnatriene-17α,21-diol-3,20-dione 21-acetate - 2-Furoyl Chloride-Dichloromethane - 4-Dimethylamino)pyridine.
Production Process of Mometasone (Nasonex)
The extensive mometasone (Nasonex) production cost report consists of the following industrial production processes:
- Production via Acylation: This method of production is initiated by the acylation of 16α-methyl-1l,4,9(11)-pregnatriene-17α,21-diol-3,20-dione 21-acetate with 2-furoyl chloride in dichloromethane in the presence of 4-dimethylamino)pyridine to form 17α-furoate. Then, the obtained 17α-furoate was mixed in THF and added with 70% HClO4 in water, which facilitates the removal of an acetyl group to give hydroxyl ketone. Further, the hydroxyl group of this compound is replaced by chlorine by converting it to mesylate through the nucleophilic substitution of mesyl group by using LiCl in DMF. The obtained chloride compound is further reacted with 1,3-dichloro-5,5-dimethylhydantoin in water to produce mometasone furoate as the final product.
- Production from Epoxide: This method of reaction involves the acidic hydrolysis of epoxide in water to give a diol. The obtained diol is further reacted with dry HCL in the presence of acetic acid, which results in the formation of mometasone furoate as the final product.
Mometasone (Nasonex) belongs to the class of medicines that are known as corticodteroids. The molecular formula of the compound is C22H28Cl2O4, and its molecular weight is 427.4 g/mol. The other names of the compound are Mometasone, Mometasona, and Mometasonum. Moreover, the melting point of the compound is 218-220°C, and it does not dissolve in water. The IUPAC name of the compound is (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one. Additionally, the compounds have anti-inflammatory and dermatologic drug. This drug is available in the form of a topical formulation, lotion, and cream.
